车险费率厘定精算技术的研究与应用评述

精算技术为中国车险市场费率改革提供必要支持,可以确保费率厘定的科学性与合理性。首先,本文系统梳理了车险分类风险费率厘定精算统计模型的发展历程,并回顾参数估计方法。其次,论述了车险个体风险费率厘定的精算模型与方法,并重点评述了信度理论与奖惩系统的研究。进而,归纳出车险费率厘定精算统计模型的研究热点与发展方向。最后,指明现有研究对中国车险费率厘定精算方法的启示,并提出相关建议。     

一种面板数据分位数回归模型的工具变量方法

本文将工具变量分位数回归模型(IVQR)应用到面板数据中,结合Canay对面板分位数回归的两步估计法以及Chernozhukov对IVQR模型的估计方法,提出了两步面板分位数工具变量估计法(2S-IVFEQR),并给出相应的参数估计。本文提出的方法较已有的方法计算复杂度低,蒙特卡洛模拟结果显示在数据量不大或者处理长面板数据时,2S-IVFEQR方法要优于传统的IVFEQR方法,且运算时间短。     

半参数线性混合效应模型的联合变量选择

多数基于线性混合效应模型的变量选择方法分阶段对固定效应和随机效应进行选择,方法繁琐、易产生模型偏差,且大部分非参数和半参数的线性混合效应模型只涉及非参数部分的光滑度或者固定效应的选择,并未涉及非参变量或随机效应的选择。本文用B样条函数逼近非参数函数部分,从而把半参数线性混合效应模型转化为带逼近误差的线性混合效应模型。对随机效应的协方差矩阵采用改进的乔里斯基分解并重新参数化线性混合效应模型,接着对该模型的极大似然函数施加集群ALASSO惩罚和ALASSO惩罚两类惩罚,该法能实现非参数变量、固定效应和随机效应的联合变量选择,基于该法得出的估计量也满足相合性、稀疏性和Oracle性质。文章最后做了个数值模拟,模拟结果表明,本文提出的估计方法在变量选择的准确性、参数估计的精度两个方面均表现较好。     

Variational Bayes With Intractable Likelihood

Variational Bayes (VB) is rapidly becoming a popular tool for Bayesian inference in statistical modeling. However, the existing VB algorithms are restricted to cases where the likelihood is tractable, which precludes their use in many interesting situations such as in state--space models and in approximate Bayesian computation (ABC), where application of VB methods was previously impossible. This article extends the scope of application of VB to cases where the likelihood is intractable, but can be estimated unbiasedly. The proposed VB method therefore makes it possible to carry out Bayesian inference in many statistical applications, including state--space models and ABC. The method is generic in the sense that it can be applied to almost all statistical models without requiring too much model-based derivation, which is a drawback of many existing VB algorithms. We also show how the proposed method can be used to obtain highly accurate VB approximations of marginal posterior distributions. Supplementary material for this article is available online.     

Programming With Models: Writing Statistical Algorithms for General Model Structures With NIMBLE

We describe NIMBLE, a system for programming statistical algorithms for general model structures within R. NIMBLE is designed to meet three challenges: flexible model specification, a language for programming algorithms that can use different models, and a balance between high-level programmability and execution efficiency. For model specification, NIMBLE extends the BUGS language and creates model objects, which can manipulate variables, calculate log probability values, generate simulations, and query the relationships among variables. For algorithm programming, NIMBLE provides functions that operate with model objects using two stages of evaluation. The first stage allows specialization of a function to a particular model and/or nodes, such as creating a Metropolis-Hastings sampler for a particular block of nodes. The second stage allows repeated execution of computations using the results of the first stage. To achieve efficient second-stage computation, NIMBLE compiles models and functions via C++, using the Eigen library for linear algebra, and provides the user with an interface to compiled objects. The NIMBLE language represents a compilable domain-specific language (DSL) embedded within R. This article provides an overview of the design and rationale for NIMBLE along with illustrative examples including importance sampling, Markov chain Monte Carlo (MCMC) and Monte Carlo expectation maximization (MCEM). Supplementary materials for this article are available online.     

Geometric approach to global asymptotic stability for the SEIRS models in epidemiology

In this paper, we present a more general criterion for the global asymptotic stability of equilibria for nonlinear autonomous differential equations based on the geometric criterion developed by Li and Muldowney. By applying this criterion, we obtain some results for the global asymptotic stability of SEIRS models with constant recruitment and varying total population size. Based on these results, we give a complete affirmative answer to Liu–Hethcote–Levin conjecture. Furthermore, an affirmative answer to Li–Graef–Wang–Karsai’s problem for SEIR model with permanent immunity and varying total population size is given.     

Maximum likelihood estimation for stochastic volatility in mean models with heavy‐tailed distributions

In this article, we introduce a likelihood‐based estimation method for the stochastic volatility in mean (SVM) model with scale mixtures of normal (SMN) distributions. Our estimation method is based on the fact that the powerful hidden Markov model (HMM) machinery can be applied in order to evaluate an arbitrarily accurate approximation of the likelihood of an SVM model with SMN distributions. Likelihood‐based estimation of the parameters of stochastic volatility models, in general, and SVM models with SMN distributions, in particular, is usually regarded as challenging as the likelihood is a high‐dimensional multiple integral. However, the HMM approximation, which is very easy to implement, makes numerical maximum of the likelihood feasible and leads to simple formulae for forecast distributions, for computing appropriately defined residuals, and for decoding, that is, estimating the volatility of the process. Copyright © 2017 John Wiley & Sons, Ltd.     

Unifying pricing formula for several stochastic volatility models with jumps

In this paper, we introduce a unifying approach to option pricing under continuous‐time stochastic volatility models with jumps. For European style options, a new semi‐closed pricing formula is derived using the generalized complex Fourier transform of the corresponding partial integro‐differential equation. This approach is successfully applied to models with different volatility diffusion and jump processes. We also discuss how to price options with different payoff functions in a similar way. In particular, we focus on a log‐normal and a log‐uniform jump diffusion stochastic volatility model, originally introduced by Bates and Yan and Hanson, respectively. The comparison of existing and newly proposed option pricing formulas with respect to time efficiency and precision is discussed. We also derive a representation of an option price under a new approximative fractional jump diffusion model that differs from the aforementioned models, especially for the out‐of‐the money contracts. Copyright © 2017 John Wiley & Sons, Ltd.     

AEIV结合AHSI用于饱和脂肪酮类物质的13C NMR谱模拟

应用一种反映分子局部微环境描述子--原子电性相互作用矢量（vector of atomic electronegative interaction,AEIV）和原子杂化状态指数（Atomic Hybridation State Index, AHSI）对饱和脂肪酮类化合物的55种分子中的153个¹³C NMR谱建模模拟,应用多元线性回归方法得到定量结构波谱关系(QSSR)模型的复相关系数R_MM=0.997, 标准偏差为SD_MM=7.155. 采用留一法交互检验的结果是R_CV=0.993,SD_CV=10.195. 并随机抽出三部分分子进行检验,得到的相关系数分别是R_MM1=0.996,R_MM2=0.996,R_MM3=0.999. 研究结果表明使用AEIV和AHSI所建模型预测能力是相当稳定的.     

A Multi-Objective Approach for Drug Repurposing in Preeclampsia

Preeclampsia is a hypertensive disorder that occurs during pregnancy. It is a complex disease with unknown pathogenesis and the leading cause of fetal and maternal mortality during pregnancy. Using all drugs currently under clinical trial for preeclampsia, we extracted all their possible targets from the DrugBank and ChEMBL databases and labeled them as “targets”. The proteins labeled as “off-targets” were extracted in the same way but while taking all antihypertensive drugs which are inhibitors of ACE and/or angiotensin receptor antagonist as query molecules. Classification models were obtained for each of the 55 total proteins (45 targets and 10 off-targets) using the TPOT pipeline optimization tool. The average accuracy of the models in predicting the external dataset for targets and off-targets was 0.830 and 0.850, respectively. The combinations of models maximizing their virtual screening performance were explored by combining the desirability function and genetic algorithms. The virtual screening performance metrics for the best model were: the Boltzmann-Enhanced Discrimination of ROC (BEDROC)_α=160.9 = 0.258, the Enrichment Factor (EF)_1% = 31.55 and the Area Under the Accumulation Curve (AUAC) = 0.831. The most relevant targets for preeclampsia were: AR, VDR, SLC6A2, NOS3 and CHRM4, while ABCG2, ERBB2, CES1 and REN led to the most relevant off-targets. A virtual screening of the DrugBank database identified estradiol, estriol, vitamins E and D, lynestrenol, mifrepristone, simvastatin, ambroxol, and some antibiotics and antiparasitics as drugs with potential application in the treatment of preeclampsia.